WCI

RI Related News

비회원이 작성한 글입니다!

글작성시 입력했던 비밀번호를 입력해주세요.

List Next Prev
게시글 내용
MTTI partners with Evergreen to Manufacture EvaThera Platform of Radiopharmaceuticals
2022/01/06

Molecular Targeting Technologies, Inc. (MTTI), USA and Evergreen Theragnostics, Inc., USA recently announced an agreement in which Evergreen will manufacture MTTI's EvaThera™ platform of radiopharmaceuticals.

 

Evergreen will manufacture MTTI clinical supplies from its newly commissioned facility in Springfield, NJ and will leverage the team's broad experience with Lu-177 based radiotherapeutics by providing comprehensive supply chain management from isotope sourcing to drug delivery at the clinical trial site.

 

To read more please visit:

MTTI partners with Evergreen to Manufacture EvaThera Platform of Radiopharmaceuticals

Source: MTTI